BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
indrayani biotech ltd. stock

INDRAYANI BIOTECH LTD. Share Price

36.24 -0.23 (-0.63%)
Dec 12 2024 03:12 PM Hotels & Restaurants NSE: INDRANIB

INDRAYANI BIOTECH LTD. Share Price Update

As of the latest trading session, INDRAYANI BIOTECH LTD. share price is currently at 36.24, which is down by -0.23 from its previous closing. Today, the stock has fluctuated between 36.00 and 37.30. Over the past year, INDRAYANI BIOTECH LTD. has achieved a return of -38.38 %. In the last month alone, the return has been -21.64 %. Read More...

INDRAYANI BIOTECH LTD. Performance

Day Range

Low36.00 High37.30
36.05

52 Week Range

Low 35.00 High 99.70
36.05

INDRAYANI BIOTECH LTD. Share Price

526445

INDRANIB

img img img img
No Data Available

Open Price

37.30

Prev. Close

36.48

Volume (Shares)

21541.00

Total traded value

7.76

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

INDRAYANI BIOTECH LTD. Fundamentals


(Standalone)

Market Cap (Cr) 165.02
PE Ratio (TTM) 304.00
Book Value / Share 11.88
Beta 0.57
ROE 2.78%
EPS (TTM) 0.12
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.10

INDRAYANI BIOTECH LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 9.51
Operating Expense 10.27
Net Profit 0.10
Net Profit Margin (%) 1.05
Earnings Per Share (EPS) 0.02
EBITDA 2.34
Effective Tax Rate (%) 23.07
Particulars JUN 2024 (Values in Cr)
Revenue 10.79
Operating Expense 11.65
Net Profit 0.13
Net Profit Margin (%) 1.20
Earnings Per Share (EPS) 0.03
EBITDA 2.01
Effective Tax Rate (%) 23.52
Particulars MAR 2024 (Values in Cr)
Revenue 15.80
Operating Expense 17.62
Net Profit 0.07
Net Profit Margin (%) 0.44
Earnings Per Share (EPS) 0.08
EBITDA 4.43
Effective Tax Rate (%) 95.67
Particulars DEC 2023 (Values in Cr)
Revenue 13.69
Operating Expense 13.51
Net Profit 0.26
Net Profit Margin (%) 1.89
Earnings Per Share (EPS) 0.06
EBITDA 1.41
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 16.01
Operating Expense 15.70
Net Profit 0.41
Net Profit Margin (%) 2.56
Earnings Per Share (EPS) 0.12
EBITDA 1.40
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 62.32
Operating Expense 62.94
Net Profit 1.46
Net Profit Margin (%) 2.34
Earnings Per Share (EPS) 0.32
EBITDA 9.29
Effective Tax Rate (%) 51.49
Particulars MAR 2023 (Values in Cr)
Revenue 74.48
Operating Expense 69.54
Net Profit 5.06
Net Profit Margin (%) 6.79
Earnings Per Share (EPS) 1.48
EBITDA 8.79
Effective Tax Rate (%) 0.39
Particulars MAR 2022 (Values in Cr)
Revenue 57.99
Operating Expense 53.98
Net Profit 4.23
Net Profit Margin (%) 7.29
Earnings Per Share (EPS) 1.23
EBITDA 6.45
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 21.01
Operating Expense 28.05
Net Profit -10.89
Net Profit Margin (%) -51.83
Earnings Per Share (EPS) -3.18
EBITDA -8.53
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 49.90
Operating Expense 49.29
Net Profit 0.81
Net Profit Margin (%) 1.62
Earnings Per Share (EPS) 0.24
EBITDA 2.96
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 13.86
ROE % 18.22
ROCE % 13.76
Total Debt to Total Equity 1.49
EBITDA Margin 14.97
Particulars MAR 2023 (Values in Cr)
Book Value / Share 12.94
ROE % 29.31
ROCE % 19.98
Total Debt to Total Equity 1.12
EBITDA Margin 13.07
Particulars MAR 2022 (Values in Cr)
Book Value / Share 7.06
ROE % 16.46
ROCE % 14.34
Total Debt to Total Equity 0.78
EBITDA Margin 11.35
Particulars MAR 2021 (Values in Cr)
Book Value / Share 5.76
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.58
EBITDA Margin -22.19
Particulars MAR 2020 (Values in Cr)
Book Value / Share 0.70
ROE % 2.37
ROCE % 4.09
Total Debt to Total Equity 0.45
EBITDA Margin 5.95
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.07
ROE % 2.78
ROCE % 7.23
Total Debt to Total Equity 1.00
EBITDA Margin 15.12
Particulars MAR 2023 (Values in Cr)
Book Value / Share 11.79
ROE % 12.48
ROCE % 10.59
Total Debt to Total Equity 0.79
EBITDA Margin 11.90
Particulars MAR 2022 (Values in Cr)
Book Value / Share 7.06
ROE % 15.61
ROCE % 14.18
Total Debt to Total Equity 0.73
EBITDA Margin 11.14
Particulars MAR 2021 (Values in Cr)
Book Value / Share 5.83
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.57
EBITDA Margin -20.94
Particulars MAR 2020 (Values in Cr)
Book Value / Share 0.70
ROE % 4.83
ROCE % 8.18
Total Debt to Total Equity 0.48
EBITDA Margin 5.95
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.58
Total Assets 235.02
Total Liabilities 235.02
Total Equity 76.26
Share Outstanding 45536256
Price to Book Ratio 4.44
Return on Assets (%) 2.70
Return on Capital (%) 3.46
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.03
Total Assets 155.96
Total Liabilities 155.96
Total Equity 48.35
Share Outstanding 34227192
Price to Book Ratio 4.79
Return on Assets (%) 5.60
Return on Capital (%) 7.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.50
Total Assets 51.40
Total Liabilities 51.40
Total Equity 24.56
Share Outstanding 34227192
Price to Book Ratio 4.32
Return on Assets (%) 8.63
Return on Capital (%) 10.46
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.67
Total Assets 40.05
Total Liabilities 40.05
Total Equity 20.08
Share Outstanding 34227192
Price to Book Ratio 1.09
Return on Assets (%) -27.99
Return on Capital (%) -31.49
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.40
Total Assets 51.47
Total Liabilities 51.47
Total Equity 30.83
Share Outstanding 3643860
Price to Book Ratio 11.93
Return on Assets (%) 1.56
Return on Capital (%) 1.81
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.26
Total Assets 126.00
Total Liabilities 126.00
Total Equity 54.51
Share Outstanding 45536256
Price to Book Ratio 4.44
Return on Assets (%) 1.15
Return on Capital (%) 1.29
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.61
Total Assets 100.29
Total Liabilities 100.29
Total Equity 51.14
Share Outstanding 34227192
Price to Book Ratio 4.79
Return on Assets (%) 5.04
Return on Capital (%) 5.85
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.44
Total Assets 49.43
Total Liabilities 49.43
Total Equity 24.17
Share Outstanding 34227192
Price to Book Ratio 4.32
Return on Assets (%) 8.54
Return on Capital (%) 10.33
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.62
Total Assets 39.84
Total Liabilities 39.84
Total Equity 19.95
Share Outstanding 34227192
Price to Book Ratio 1.09
Return on Assets (%) -27.32
Return on Capital (%) -30.77
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.40
Total Assets 51.47
Total Liabilities 51.47
Total Equity 30.83
Share Outstanding 3643860
Price to Book Ratio 11.93
Return on Assets (%) 1.56
Return on Capital (%) 1.81
Particulars MAR 2024 (Values in Cr)
Net Income 10.42
Cash from Operations -30.35
Cash from Investing -16.33
Cash from Financing 44.23
Net change in Cash -2.45
Free Cash Flow -13.86
Particulars MAR 2023 (Values in Cr)
Net Income 11.93
Cash from Operations 16.18
Cash from Investing -47.39
Cash from Financing 32.73
Net change in Cash 1.53
Free Cash Flow 37.71
Particulars MAR 2022 (Values in Cr)
Net Income 4.43
Cash from Operations 4.11
Cash from Investing -0.55
Cash from Financing -2.72
Net change in Cash 0.82
Free Cash Flow 5.30
Particulars MAR 2021 (Values in Cr)
Net Income -11.21
Cash from Operations 0.25
Cash from Investing -0.70
Cash from Financing -0.27
Net change in Cash -0.72
Free Cash Flow 0.95
Particulars MAR 2020 (Values in Cr)
Net Income 0.80
Cash from Operations 5.95
Cash from Investing -3.66
Cash from Financing -1.28
Net change in Cash 1.01
Free Cash Flow 9.44
Particulars MAR 2024 (Values in Cr)
Net Income 3.00
Cash from Operations 26.08
Cash from Investing -7.25
Cash from Financing -19.18
Net change in Cash -0.35
Free Cash Flow 32.43
Particulars MAR 2023 (Values in Cr)
Net Income 5.05
Cash from Operations 8.33
Cash from Investing -14.09
Cash from Financing 4.93
Net change in Cash -0.82
Free Cash Flow 10.23
Particulars MAR 2022 (Values in Cr)
Net Income 4.22
Cash from Operations 3.46
Cash from Investing 0.58
Cash from Financing -3.23
Net change in Cash 0.81
Free Cash Flow 3.52
Particulars MAR 2021 (Values in Cr)
Net Income -10.88
Cash from Operations 0.51
Cash from Investing -0.56
Cash from Financing -0.73
Net change in Cash -0.77
Free Cash Flow 0.90
Particulars MAR 2020 (Values in Cr)
Net Income 0.80
Cash from Operations 5.95
Cash from Investing -3.66
Cash from Financing -1.28
Net change in Cash 1.01
Free Cash Flow 9.44
Company Name Price P/E P/B Market Cap 52 Week Low/High
ASIAN HOTELS (NORTH) LTD 198.05 0.00 -1.60 385.27 108.25 / 238.90
EIH LIMITED 426.80 39.63 6.52 26690.54 222.75 / 566.00
GRAVISS HOSPITALITY LTD. 54.64 29.06 2.05 385.32 35.11 / 64.70
THE INDIAN HOTELS CO. LTD 836.75 83.93 11.72 119105.69 416.15 / 846.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
ARUNA HOTELS LTD. 11.92 0.00 -0.68 40.41 9.47 / 23.38
ASIAN HOTELS (NORTH) LTD 198.05 0.00 -0.97 385.27 108.25 / 238.90
EIH LIMITED 426.80 44.18 7.23 26690.54 222.75 / 566.00
GRAVISS HOSPITALITY LTD. 54.64 28.31 1.84 385.32 35.11 / 64.70

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 36.70
  • 26 Days 39.20
  • 10 Days 36.70
  • 50 Days 39.40
  • 12 Days 36.90
  • 100 Days 43.50
  • 20 Days 38.60
  • 200 Days 66.50
36.71
PIVOT
First Resistance 37.25
Second Resistance 38.02
Third Resistance 38.56
First Support 35.94
Second Support 35.40
Third Support 34.63
RSI 37.97
MACD -2.32
Commodity Channel Index (CCI) -62.16
ADX 23.85
Williams % R -77.38

Over 1 Month

down

-21.64

Over 3 Months

down

-22.56

Over 6 Months

down

-24.17

Over 1 Year

down

-38.38

Over 3 Years

down

12.60

Over 5 Years

down

44.95

INDRAYANI BIOTECH LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

INDRAYANI BIOTECH LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
45.95
Promoter Holdings
33.39
FII
0.0
DII
5.58
Promoter Shares(Pledge Percentage)
15.06
Name Category Shares Shares%
Jayaseelan Singaravelu Public Shareholding 4552327.0 10.0
G Swaminathan . Shareholding of Promoter and Promoter Group 4140000.0 9.09
Sayee Sundar Kasiraman Shareholding of Promoter and Promoter Group 2631569.0 5.78
S Indirakumar . Shareholding of Promoter and Promoter Group 2098600.0 4.61
I Umasundari . Shareholding of Promoter and Promoter Group 2098600.0 4.61
Rajasthan Global Securities Private Limited Public Shareholding 1391154.0 3.06
Ajitkumar C Patel Public Shareholding 1300000.0 2.85
Next Orbit Ventures Fund Public Shareholding 1153587.0 2.53
Malarvannan Subashini Public Shareholding 1059064.0 2.33
M Ramesh . Shareholding of Promoter and Promoter Group 1050000.0 2.31
Jothi Ramesh . Shareholding of Promoter and Promoter Group 1050000.0 2.31
Sridhar Muthuraman Public Shareholding 1000000.0 2.2
Dheeraj Kumar Lohia Public Shareholding 934172.0 2.05
Thirumeni Thiruselvaraja . Shareholding of Promoter and Promoter Group 802889.0 1.76
S Prakash Public Shareholding 777500.0 1.71
S I Dinesh Kumar . Shareholding of Promoter and Promoter Group 700000.0 1.54
V Agathiyan . Shareholding of Promoter and Promoter Group 632500.0 1.39
R Raja . Public Shareholding 508019.0 1.12
Ramya M . Shareholding of Promoter and Promoter Group 1400.0 0.0
K Logan . Shareholding of Promoter and Promoter Group 1400.0 0.0

INDRAYANI BIOTECH LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About INDRAYANI BIOTECH LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by INDRAYANI BIOTECH LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Indrayani Biotech Ltd?

Answer Field

The share price of Indrayani Biotech Ltd for NSE is ₹ 0.00 and for BSE is ₹ 36.07.

What is the Market Cap of Indrayani Biotech Ltd?

Answer Field

The market cap of Indrayani Biotech Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 1,64.20 Cr. as of now.

What is the 52 Week High and Low of Indrayani Biotech Ltd?

Answer Field

The 52 Week High and Low of Indrayani Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 99.70 and ₹ 35.00.

How to Buy Indrayani Biotech Ltd share?

Answer Field

You can trade in Indrayani Biotech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Indrayani Biotech Ltd?

Answer Field

The 1 year returns on the stock has been -38.38%.

What is the Current Share Price of Indrayani Biotech Ltd?

Answer Field

Indrayani Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 36.07 as on Dec 12 2024 03:12 PM.

What is the Market Cap of Indrayani Biotech Ltd Share?

Answer Field

The market cap of Indrayani Biotech Ltd for NSE ₹ 0.0 & for BSE ₹ 1,64.20 as on Dec 12 2024 03:12 PM.

What is the P/E Ratio of Indrayani Biotech Ltd Share?

Answer Field

As on Dec 12 2024 03:12 PM the price-to-earnings (PE) ratio for Indrayani Biotech Ltd share is 304.00.

What is the PB ratio of Indrayani Biotech Ltd Share?

Answer Field

As on Dec 12 2024 03:12 PM, the price-to-book (PB) ratio for Indrayani Biotech Ltd share is 11.88.

How to Buy Indrayani Biotech Ltd Share?

Answer Field

You can trade in Indrayani Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Indrayani Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Indrayani Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Indrayani Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader